Who
Chris T. Bitterman
Vice Pres Sales & Marketing
Company insider
Files Form 4 as: Vice Pres Sales & Marketing, Cumberland Pharmaceuticals.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 Mar 2023
- Last trade
- 18 Mar 2026
- Last filed
- 20 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $8,4003,000 at $2.80 | filing |
| 18 Mar 2026filed 20 Mar 2026 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $8,4003,000 at $2.80 | filing |
| 17 Mar 2025filed 18 Mar 2025 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $14K2,750 at $5.17 | filing |
| 25 Mar 2024filed 26 Mar 2024 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $4,7032,750 at $1.71 | filing |
| 23 Mar 2024filed 26 Mar 2024 | CPIX Cumberland PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $1,073593 at $1.81 | filing |
| 24 Mar 2023filed 27 Mar 2023 | CPIX Cumberland Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.